Preeclampsia Linked to Risk of Maternal Retinal Disease

Share this content:
Preeclampsia Linked to Risk of Maternal Retinal Disease
Preeclampsia Linked to Risk of Maternal Retinal Disease

WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- Preeclampsia is associated with increased risk of maternal retinal disease, especially traction detachments, retinal breaks, and diabetic retinopathy, according to a study published in the January issue of Obstetrics & Gynecology.

Nathalie Auger, M.D., from the University of Montreal Hospital Research Center, and colleagues conducted a longitudinal cohort study of 1,108,541 women who delivered neonates between 1989 and 2013. Women were tracked for later hospitalizations through March 2014. The authors examined the correlation between preeclampsia, which was measured at delivery and categorized by severity and onset, and retinal disease.

The researchers found that women with preeclampsia had a higher incidence of hospitalization for retinal detachment, retinopathy, and other retinal disorders compared to those with no preeclampsia. The strongest associations were seen for preeclampsia with traction detachments, retinal breaks, and diabetic retinopathy (hazard ratios, 2.39, 2.48, and 4.13, respectively). The risk was even higher for severe and early-onset preeclampsia compared with mild or late-onset preeclampsia.

"Preeclampsia, particularly severe or early-onset preeclampsia, is associated with an increased risk of maternal retinal disease in the decades after pregnancy," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »